Denosumab and the Risk of Diabetes in Patients Treated for Osteoporosis

德诺苏马布 骨质疏松症 医学 倾向得分匹配 糖尿病 危险系数 混淆 内科学 比例危险模型 兰克尔 肿瘤科 葡萄糖稳态 内分泌学 胰岛素 胰岛素抵抗 受体 置信区间 激活剂(遗传学)
作者
Huei‐Kai Huang,Alice Chuang,Tzu‐Chi Liao,Shih‐Chieh Shao,Peter Pin‐Sung Liu,Yu‐Kang Tu,Edward Chia‐Cheng Lai
出处
期刊:JAMA network open [American Medical Association]
卷期号:7 (2): e2354734-e2354734 被引量:4
标识
DOI:10.1001/jamanetworkopen.2023.54734
摘要

Importance Denosumab, a humanized monoclonal antibody against receptor activator of nuclear factor κB ligand (RANKL), is a widely used antiresorptive medication for osteoporosis treatment. Recent preclinical studies indicate that inhibition of RANKL signaling improves insulin sensitivity, glucose tolerance, and β-cell proliferation, suggesting that denosumab may improve glucose homeostasis; however, whether denosumab reduces the risk of incident diabetes remains unclear. Objective To evaluate whether denosumab use is associated with a lower risk of developing diabetes in patients with osteoporosis. Design, Setting, and Participants This nationwide, propensity score–matched cohort study used administrative data from Taiwan’s National Health Insurance Research Database. Adult patients who received denosumab for osteoporosis therapy in Taiwan between 2012 and 2019 were included. To eliminate the inherent bias from confounding by indication, the patients were categorized into a treatment group (34 255 patients who initiated denosumab treatment and adhered to it) and a comparison group (34 255 patients who initiated denosumab treatment but discontinued it after the initial dose) according to the administration status of the second dose of denosumab. Propensity score matching was performed to balance patient characteristics and to control for confounders. Exposure Treatment with denosumab. Main Outcomes and Measures The primary outcome was incident diabetes requiring treatment with antidiabetic drugs. A Cox proportional hazards model was used to estimate the hazard ratio (HR) for incident diabetes. Data were analyzed from January 1 to November 30, 2023. Results After propensity score matching, 68 510 patients were included (mean [SD] age, 77.7 [9.8] years; 57 762 [84.3%] female). During a mean (SD) follow-up of 1.9 (1.6) years, 2016 patients developed diabetes in the treatment group and 3220 developed diabetes in the comparison group (incidence rate, 35.9 vs 43.6 per 1000 person-years). Compared with the comparison group, denosumab treatment was associated with a lower risk of incident diabetes (HR, 0.84; 95% CI, 0.78-0.90). Several sensitivity analyses also demonstrated similar results of lower diabetes risk associated with denosumab treatment. Conclusions and relevance The results from this cohort study indicating that denosumab treatment was associated with lower risk of incident diabetes may help physicians choose an appropriate antiosteoporosis medication for patients with osteoporosis while also considering the risk of diabetes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
4秒前
沈静完成签到,获得积分10
4秒前
6秒前
loski发布了新的文献求助10
6秒前
marina完成签到 ,获得积分20
7秒前
10秒前
时尚俊驰发布了新的文献求助10
10秒前
11秒前
文献发布了新的文献求助30
12秒前
15秒前
我嘞个豆完成签到,获得积分10
15秒前
爱笑晓曼发布了新的文献求助10
16秒前
wdy111应助sc采纳,获得20
16秒前
敏感初露发布了新的文献求助10
16秒前
隐形曼青应助机智思真采纳,获得10
19秒前
思源应助时尚俊驰采纳,获得10
19秒前
可爱的函函应助敏感初露采纳,获得10
19秒前
20秒前
爆米花应助橙子采纳,获得10
23秒前
量子星尘发布了新的文献求助10
25秒前
阿满完成签到 ,获得积分10
26秒前
王馨雨完成签到,获得积分10
27秒前
在水一方应助袁涛采纳,获得10
27秒前
爱笑晓曼完成签到,获得积分10
30秒前
31秒前
32秒前
nuoran发布了新的文献求助10
33秒前
33秒前
乐乐宝完成签到,获得积分10
34秒前
35秒前
彭于晏应助阿钉采纳,获得10
36秒前
孙燕应助阿钉采纳,获得10
36秒前
整齐小松鼠应助阿钉采纳,获得10
36秒前
jszhoucl发布了新的文献求助10
37秒前
一定行发布了新的文献求助10
37秒前
jxlu发布了新的文献求助10
38秒前
40秒前
橙子发布了新的文献求助10
40秒前
科研通AI5应助科研通管家采纳,获得10
41秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989378
求助须知:如何正确求助?哪些是违规求助? 3531442
关于积分的说明 11254002
捐赠科研通 3270126
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809173